New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: Translational and sex-specific effects

Ana Paula Davel, Iris Z. Jaffe, Rita C. Tostes, Frederic Jaisser, Eric Jacques Belin de Chantemele

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Recent advances in the field of mineralocorticoid receptor (MR) and its ligand aldosterone expanded the role of this hormone and its receptor far beyond their initial function as a regulator of Na+ and K+ homeostasis in epithelial cells. The symposium “New Roles of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease: Translational and Sex-Specific Effects” presented at the 38th World Congress of the International Union of Physiological Sciences (Rio de Janeiro, Brazil) highlighted the contribution of extrarenal MRs to cardiovascular disease. This symposium showcased how MRs expressed in endothelial, vascular smooth muscle, and immune cells plays a critical role in the development of vascular disease associated with aging, obesity, and chronic aldosterone stimulation and demonstrated that MR antagonism prevents the acute renal dysfunction and tubular injury induced by ischemia-reperfusion injury. It was also shown that the adipocyte-derived hormone leptin is a new direct regulator of aldosterone secretion and that leptin-mediated aldosterone production is a major contributor to obesity-associated hypertension in women. Sex differences in the role of aldosterone and of endothelial MR in the cardiovascular outcomes of obesity were highlighted. This review summarizes these important emerging concepts regarding the contribution of aldosterone and cell-specific MR to cardiovascular disease in male and female subjects and further supports sex-specific benefits of MR antagonist drugs to be tested in additional populations.

Original languageEnglish (US)
Pages (from-to)H989-H999
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume315
Issue number4
DOIs
StatePublished - Oct 1 2018

Fingerprint

Mineralocorticoid Receptors
Aldosterone
Cardiovascular Diseases
Obesity
Leptin
Hormones
Mineralocorticoid Receptor Antagonists
Reperfusion Injury
Vascular Diseases
Vascular Smooth Muscle
Adipocytes
Sex Characteristics
Smooth Muscle Myocytes
Brazil
Homeostasis
Epithelial Cells
Ligands
Hypertension
Kidney
Wounds and Injuries

Keywords

  • Aging
  • Aldosterone
  • Hypertension
  • Kidney
  • Mineralocorticoid receptor

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease : Translational and sex-specific effects. / Davel, Ana Paula; Jaffe, Iris Z.; Tostes, Rita C.; Jaisser, Frederic; Belin de Chantemele, Eric Jacques.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 315, No. 4, 01.10.2018, p. H989-H999.

Research output: Contribution to journalReview article

@article{cb300301a2514408911c41cca4883637,
title = "New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: Translational and sex-specific effects",
abstract = "Recent advances in the field of mineralocorticoid receptor (MR) and its ligand aldosterone expanded the role of this hormone and its receptor far beyond their initial function as a regulator of Na+ and K+ homeostasis in epithelial cells. The symposium “New Roles of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease: Translational and Sex-Specific Effects” presented at the 38th World Congress of the International Union of Physiological Sciences (Rio de Janeiro, Brazil) highlighted the contribution of extrarenal MRs to cardiovascular disease. This symposium showcased how MRs expressed in endothelial, vascular smooth muscle, and immune cells plays a critical role in the development of vascular disease associated with aging, obesity, and chronic aldosterone stimulation and demonstrated that MR antagonism prevents the acute renal dysfunction and tubular injury induced by ischemia-reperfusion injury. It was also shown that the adipocyte-derived hormone leptin is a new direct regulator of aldosterone secretion and that leptin-mediated aldosterone production is a major contributor to obesity-associated hypertension in women. Sex differences in the role of aldosterone and of endothelial MR in the cardiovascular outcomes of obesity were highlighted. This review summarizes these important emerging concepts regarding the contribution of aldosterone and cell-specific MR to cardiovascular disease in male and female subjects and further supports sex-specific benefits of MR antagonist drugs to be tested in additional populations.",
keywords = "Aging, Aldosterone, Hypertension, Kidney, Mineralocorticoid receptor",
author = "Davel, {Ana Paula} and Jaffe, {Iris Z.} and Tostes, {Rita C.} and Frederic Jaisser and {Belin de Chantemele}, {Eric Jacques}",
year = "2018",
month = "10",
day = "1",
doi = "10.1152/ajpheart.00073.2018",
language = "English (US)",
volume = "315",
pages = "H989--H999",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease

T2 - Translational and sex-specific effects

AU - Davel, Ana Paula

AU - Jaffe, Iris Z.

AU - Tostes, Rita C.

AU - Jaisser, Frederic

AU - Belin de Chantemele, Eric Jacques

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Recent advances in the field of mineralocorticoid receptor (MR) and its ligand aldosterone expanded the role of this hormone and its receptor far beyond their initial function as a regulator of Na+ and K+ homeostasis in epithelial cells. The symposium “New Roles of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease: Translational and Sex-Specific Effects” presented at the 38th World Congress of the International Union of Physiological Sciences (Rio de Janeiro, Brazil) highlighted the contribution of extrarenal MRs to cardiovascular disease. This symposium showcased how MRs expressed in endothelial, vascular smooth muscle, and immune cells plays a critical role in the development of vascular disease associated with aging, obesity, and chronic aldosterone stimulation and demonstrated that MR antagonism prevents the acute renal dysfunction and tubular injury induced by ischemia-reperfusion injury. It was also shown that the adipocyte-derived hormone leptin is a new direct regulator of aldosterone secretion and that leptin-mediated aldosterone production is a major contributor to obesity-associated hypertension in women. Sex differences in the role of aldosterone and of endothelial MR in the cardiovascular outcomes of obesity were highlighted. This review summarizes these important emerging concepts regarding the contribution of aldosterone and cell-specific MR to cardiovascular disease in male and female subjects and further supports sex-specific benefits of MR antagonist drugs to be tested in additional populations.

AB - Recent advances in the field of mineralocorticoid receptor (MR) and its ligand aldosterone expanded the role of this hormone and its receptor far beyond their initial function as a regulator of Na+ and K+ homeostasis in epithelial cells. The symposium “New Roles of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease: Translational and Sex-Specific Effects” presented at the 38th World Congress of the International Union of Physiological Sciences (Rio de Janeiro, Brazil) highlighted the contribution of extrarenal MRs to cardiovascular disease. This symposium showcased how MRs expressed in endothelial, vascular smooth muscle, and immune cells plays a critical role in the development of vascular disease associated with aging, obesity, and chronic aldosterone stimulation and demonstrated that MR antagonism prevents the acute renal dysfunction and tubular injury induced by ischemia-reperfusion injury. It was also shown that the adipocyte-derived hormone leptin is a new direct regulator of aldosterone secretion and that leptin-mediated aldosterone production is a major contributor to obesity-associated hypertension in women. Sex differences in the role of aldosterone and of endothelial MR in the cardiovascular outcomes of obesity were highlighted. This review summarizes these important emerging concepts regarding the contribution of aldosterone and cell-specific MR to cardiovascular disease in male and female subjects and further supports sex-specific benefits of MR antagonist drugs to be tested in additional populations.

KW - Aging

KW - Aldosterone

KW - Hypertension

KW - Kidney

KW - Mineralocorticoid receptor

UR - http://www.scopus.com/inward/record.url?scp=85054059132&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054059132&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00073.2018

DO - 10.1152/ajpheart.00073.2018

M3 - Review article

C2 - 29957022

AN - SCOPUS:85054059132

VL - 315

SP - H989-H999

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 4

ER -